Walpar Nutritions Ltd.
NNSE:WALPAR26.10
INR
0.00
(0.00%)
ISIN
INE0G2G01015
Return %
Stock
S&P 500
1Y
-43.26
14.20
3Y
-70.00
81.12
5Y
-25.43
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Gandhinagar India
- IPO Date
- Jul 13, 2021
- Website
- walparnutritions.com
- Similar Companies
- Business
- Walpar Nutritions Limited is an India-based company engaged in the research, development, manufacturing, marketing, and contract manufacturing of nutraceuticals, dietary supplements, herbal formulations, and pharmaceutical wellness products. The company operates primarily through its Contract Manufacturing and Third-Party Private Labeling division and its Proprietary Brand Sales division, serving domestic pharmaceutical companies, fast-moving consumer goods (FMCG) enterprises, direct-to-consumer (D2C) wellness brands, and international distributors. The company offers a comprehensive product portfolio across diverse therapeutic and health categories, comprising general wellness and immunity supplements containing multivitamins, multiminerals, vitamin C, and zinc; bone and joint health formulations including calcium, vitamin D3, glucosamine, and chondroitin; cardiovascular and metabolic health products featuring omega-3 fish oil, coenzyme Q10, and plant sterols; digestive wellness formulations incorporating multi-strain probiotics, prebiotic fibers, and digestive enzyme complexes; sports nutrition and energy supplements consisting of whey protein powders, branched-chain amino acids, creatine, and performance blends; women's health and prenatal care formulations with folic acid, iron, and specialized micronutrients; cognitive and neurological health supplements; dermatological and cosmetic nutrition products formulated with marine collagen peptides, biotin, and glutathione; and herbal and Ayurvedic remedies containing standardized botanical extracts such as ashwagandha, curcumin, and moringa. Walpar Nutritions delivers these formulations across various dosage forms and delivery mechanisms, including hard gelatin, soft gelatin, and vegetarian cellulose capsules; sustained-release, chewable, and effervescent tablets; oral liquids, syrups, and drops; nutritional powders and granules packed in jars and sachets; and pectin- and gelatin-based gummy vitamins. The company also provides integrated contract manufacturing services, encompassing formulation development, laboratory quality testing, stability studies, custom packaging design, and regulatory compliance support. In recent developments, Walpar Nutritions has expanded its manufacturing infrastructure by commissioning upgraded production lines with high-speed automated encapsulation, effervescent tableting, and gummy manufacturing capabilities compliant with Good Manufacturing Practice (GMP), ISO, and HACCP standards. The company has broadened its product catalog to emphasize fast-growing functional formats, notably launching specialized gummy formulations, effervescent electrolyte drinks, and plant-based protein powders to address expanding consumer demand in the preventative healthcare sector. Walpar Nutritions has also strengthened its strategic partnerships by entering into multi-year contract manufacturing and supply agreements with prominent domestic D2C health brands and retail pharmacy chains, while accelerating its international expansion by securing regulatory product registrations and establishing distribution channels across emerging markets in Southeast Asia, Africa, and the Middle East. Founded in 2009, Walpar Nutritions Limited is headquartered in Ahmedabad, Gujarat, India, where it operates its primary manufacturing and testing facilities.